MDR1/P-glycoprotein in haematological neoplasms
- 1 June 1996
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 32 (6) , 1034-1038
- https://doi.org/10.1016/0959-8049(96)00055-x
Abstract
No abstract availableThis publication has 58 references indexed in Scilit:
- P-Glycoprotein Expression in Acute Myeloblasts Leukemia Analyzed by Immunocytochemistry and Flow CytometryLeukemia & Lymphoma, 1995
- P-glycoprotein-mediated multidrug resistance in normal and neoplastic hematopoietic cellsAnnals of Hematology, 1994
- P-glycoprotein expression and function in circulating blood cells from normal volunteersBlood, 1994
- Clinical relevance of P-glycoprotein expression in haematological malignanciesLeukemia Research, 1994
- Clinical application of a rapid, functional assay for multidrug resistance based on accumulation of the fluorescent dye, fluo-3European Journal Of Cancer, 1993
- Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype [see comments]Blood, 1992
- Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes [see comments]Blood, 1992
- Various Methods of Analysis of mdr-1/P-Glycoprotein in Human Colon Cancer Cell LinesJNCI Journal of the National Cancer Institute, 1992
- Expression of P-glycoprotein in adult T-cell leukemia cellsBlood, 1990
- Multidrug-resistance phenotype of a subpopulation of T-lymphocytes without drug selectionExperimental Cell Research, 1989